{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ03202",
      "entity_text" : "phospholipase",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P04054",
      "entity_text" : "PLA2",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Numerous preclinical studies have demonstrated the neuroprotective effects of CDPC through stimulation of the synthesis of brain phospholipids, prevention of phospholipase A2 (PLA2) activation, and reduction of oxidative stress XREF_BIBR, XREF_BIBR.",
  "reading_complete" : "2020-08-03T17:55:57Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T17:53:30Z",
  "trigger" : "prevention",
  "evidence" : [ "prevention of phospholipase A2 (PLA2" ],
  "pmc_id" : "4955057",
  "score" : 0
}